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We, the coordinators of the projects GRACE, G-TwYST 
and GMO90+ described below, agreed on a coordinated 
publication strategy to increase the transparency of our 
studies and—in addition to the stakeholder involvement 
activities in our own projects—to invite stakeholders to dis-
cuss the data generated by our projects in the frame of a 
scientific debate in an open-access journal. Therefore, we 
invite the Editor-in-chief of “Archives of Toxicology” to 
develop with us a process facilitating a transparent and tai-
lored scientific discussion about the results of our research 
projects to be published. Our suggestion includes an open-
access publication of the accepted GRACE, G-TwYST and 
GMO90+ manuscripts and further comprises the establish-
ment of a discussion forum being maintained by the pub-
lisher. The forum should provide a platform for a solely 
evidence-based exchange of opinions, thereby objectifying 
the dispute about the adequacy of animal feeding trials with 
whole food/feed for the risk assessment of GMPs. The dis-
cussion forum will be opened with the publication of the 
first GRACE manuscript on two 90-day feeding trials, “90-
day oral toxicity studies on two genetically modified maize 
MON810 varieties in Wistar Han RCC rats.”
GRACE (GMO Risk Assessment and Communication of 
Evidence) is a research project under the 7th Framework 
Program of the European Commission, starting in June 
2012 with a duration of 3.5 years. It aims to increase the 
transparency, traceability and accessibility of information 
dealing with potential risks and benefits associated with the 
deliberate release of GMPs and products derived thereof. 
Besides the elaboration of systematic, transparent and 
inclusive reviews of existing evidence on potential health, 
environmental, and socioeconomic impacts of GMPs, one 
key objective is to reconsider the design, execution, and 
interpretation of animal feeding trials as well as in vitro 
and in silico approaches with whole food/feed and to 
The added value of animal feeding trials as well as in vitro 
and in silico approaches with whole food/feed for the risk 
assessment of genetically modified plants (GMPs) is a mat-
ter of persistent public debate when assessing the environ-
mental and health risks. In the frame of two EU-funded 
projects (GRACE and G-TwYST) and several projects 
funded by European Member States (e.g., the French pro-
ject GMO90+), animal feeding trials as well as in vitro 
and in silico approaches with whole GM food/feed are 
performed. To explore the added value of close coopera-
tion and to reconsider the design, execution and interpre-
tation of animal feeding trials as well as in vitro and in 
silico approaches, the above-mentioned projects agreed 
on exchanging material and data and are performing 
subchronic, chronic and carcinogenicity studies with two 
GM events in a highly coordinated manner. Other Euro-
pean research projects to investigate the added value of ani-
mal feeding trials for GMP risk assessment are invited to 
exchange material and data with us too.
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determine their added value for the risk assessment of 
GMPs. Animal feeding trials with GM maize MON810 
will cover a duration of 90 days and 1 year and will follow 
internationally accepted guidelines and recommendations. 
This central pillar of GRACE is of special importance in 
the light of the new Implementing Regulation (EU) No. 
503/2013 on applications for EU market authorization of 
genetically modified food and feed. According to this Reg-
ulation, it is mandatory to perform a 90-day rodent feeding 
study for single transformation events, whereas “the Com-
mission shall monitor the application of this Regulation, 
the developments in scientific knowledge on replacement, 
reduction and refinement of animal use in scientific proce-
dures and the publication of new guidance from EFSA. The 
Commission shall in particular monitor the outcome of the 
research project called GRACE…”.1 Throughout the whole 
planning and interpretation stage, special emphasis is 
placed on active stakeholder involvement in order to con-
sider the inputs from external experts on the scientific road-
map of GRACE, to increase transparency and to strengthen 
the relevance of the gathered results from a broader societal 
perspective (more detailed information on the GRACE 
stakeholder involvement strategy can be found on 
http://www.grace-fp7.eu/). Furthermore, all raw data will 
be made available for public scrutiny via the open-access 
database CADIMA (Central Access Database for the 
Impact Assessment of Crop Genetic Improvement Technol-
ogies, http://www.cadima.info/).
G-TwYST (GMP-Two Year Safety Testing) is also a 
research project under the 7th Framework Program of the 
European Commission, starting in April 2014 for a period 
of 4 years. G-TwYST will perform a 90-day as well as a 
combined 2-year chronic toxicity/carcinogenicity study 
with the GM maize NK603 and a 2-year carcinogenicity 
study with the GM maize MON810 based on OECD Test 
Guidelines and according to EFSA considerations. Fur-
thermore, the project will define criteria to evaluate the 
scientific quality of long-term feeding studies and develop 
recommendations (scientific justification) on the added 
value of long-term feeding trials in the frame of the GMO 
risk assessment process. Partners will strictly comply with 
international standards and norms concerning feeding tri-
als. Feeding stuff used in the trials will be produced accord-
ing to the principles of good agricultural practice. Trans-
parency and accessibility of project plans and results are 
a key characteristic of the project and will be ensured by 
1
 Implementing Regulation (EU) (2013) Commission Implement-
ing Regulation (EU) No. 503/2013 on applications for authorisation 
of genetically modified food and feed in accordance with Regulation 
(EC) No. 1829/2003 of the European Parliament and of the Council 
and amending Commission Regulations (EC) No. 641/2004 and (EC) 
No. 1981/2006. OJ L 157, 8.6.2013, pp. 1–48.
establishing a project website and by using the open-access 
database (CADIMA) setup by GRACE as information 
hubs. The results will be published as open-access journal 
papers. By combining the results of the G-TwYST pro-
ject with those of the GRACE project (90-day and 1-year 
study with the GM maize MON810), it will be possible 
for the first time to investigate potential medium-term and 
long-term toxic effects of the two above-mentioned events. 
G-TwYST will engage with stakeholders and inform the 
broader public and policy makers about the quality criteria 
for the evaluation and performance of feeding studies, their 
value and necessity, and in this context will discuss broader 
societal issues. The results of the project will enable risk 
managers drawing conclusions with regard to framework 
of the currently applicable GM food/feed risk assessment 
requirements and procedures in the EU.
GMO90+ (Genetically modified organism, 90-day to 
180-day testing) is a research project aimed at improving 
the 90-day subchronic toxicity testing in rats. The project is 
supported by the Ministry of Ecology, Sustainable Devel-
opment and Energy (MEDDE) with a grant of 2.5 million 
€, for a period of 3 years starting in 2014. GMO90+ will 
be unique as it brings together diverse scientific expertise 
in the area of crop production and analytical characteri-
zation, systems biology, conventional toxicology, statis-
tics and modeling as well as social sciences and humani-
ties. This project is based on a consortium of teams from 
laboratories at INRA (National Institute in Agronomy), 
INSERM (National Institute in Human Health), CNRS 
(National Institute in Scientific Research), ANSES (French 
Agency for Food Environmental and Occupational Health 
and Safety) and specialized partners in statistics, mod-
eling, proteomics, and bioinformatics. The objective of 
this study is to investigate whether feeding rats with GM 
MON810 or NK603 maize may relate to biomarkers of 
effects. The GMO90+ consortium stresses the importance 
of longer studies conducted by GRACE and G-TwYST 
programs to confirm the predictive biomarkers identified in 
this project. The same crop production (fall 2014) as well 
as the same Wistar rat line will be used in the GMO90+ 
and G-TwYST/GRACE projects. Rats will be followed for 
6 months (180 days) with monthly blood and urine sam-
ples allowing the search for biomarkers by high-throughput 
(omics) techniques in conjunction with pathophysiologi-
cal analysis mainly centered on the gut, liver, kidney, and 
reproductive apparatus. The characterization and validation 
of biomarkers of interest will be discussed by the GMO90+ 
consortium in close relationship with the coordinators of 
the GRACE and G-TwYST programs. Results generated in 
the frame of GMO90+ should provide useful information 
to both academic research and regulatory agencies in order 
to improve the predictability of the 90-day rodent studies. 
The GMO90+ project is developed in a constant dialogue 
2069Arch Toxicol (2014) 88:2067–2069 
1 3
with stakeholders by insuring full transparency on this con-
troversial research object. Finally, raw data will be loaded 
in the open-access database CADIMA, and frozen tissues 
will be stored and available in a first step for the GRACE 
and G-TwYST researchers and thereafter for the research 
community in general.
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